Findings

What do systematic reviews say?

2 questions · 2 findings · 1 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 1 · 50%High 1 · 50%

Regular salmeterol vs salbutamol

All‐cause non‐fatal serious adverse events ‐ adults and adolescents · patients with chronic asthma

Regular salmeterol showed no clear difference in all‐cause non‐fatal serious adverse events ‐ adults and adolescents compared with regular salbutamol (moderate certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 0.96 [0.85, 1.1]
5 studies · 27002 participants
Moderate

Regular salmeterol vs placebo

All‐cause non‐fatal serious adverse events ‐ adults and adolescents · patients with chronic asthma

Regular salmeterol leads to higher all‐cause non‐fatal serious adverse events ‐ adults and adolescents compared with placebo (high certainty).

1 finding from 1 review

Regular treatment with salmeterol for chronic asthma: serious adverse events 2008 · Cochrane Headline outcomes only
OR 1.14 [1.01, 1.28]
13 studies · 30196 participants
High